FTC's National Noncompete Ban is Down But Is It Out?
Health Affairs' Jeff Byers welcomes Deputy Editor Chris Fleming to the program to discuss the latest hurdle to the FTC's attempt to ban noncompete agreements in employment contracts, and what the impl...
6 Syys 202415min
Universal Basic Income, Health Equity & Social Democracy w/ Seth Berkowitz
Health Affairs' Jeff Byers welcomes Seth Berkowitz of University of North Carolina at Chapel Hill School of Medicine to the program to discuss his recent book "Equal Care: Health Equity, Social Democr...
30 Elo 202427min
A Peek Behind the Medicare Drug Price Negotiation Curtain
Health Affairs' Jeff Byers welcomes Senior Editor Ellen Bayer to the program to discuss the ongoing progress of the Inflation Reduction Act of 2022, how it's being implemented, and how we can best eva...
23 Elo 202411min
The Increasing Cyber Risk of Health Care Data
Health Affairs' Jeff Byers welcomes Senior Editor Leslie Erdelack back to the program to discuss recent cybersecurity events that have affected both health care businesses and patients alike, preventi...
16 Elo 202412min
PBMs. What Are They Hiding? w/ Stacie Dusetzina
Health Affairs' Jeff Byers welcomes Stacie Dusetzina of Vanderbilt University back to the program to discuss an interim staff report released by the Federal Trade Commission (FTC) about the impact tha...
9 Elo 202423min
HHS Proposes Requirements To Advance Maternal Quality Improvement Efforts
Health Affairs' Jeff Byers welcomes Senior Editor Marianne Amoss to the program to explore the state of maternal health in health care and what a recent policy proposal from CMS could do to reduce mat...
2 Elo 202412min
The Plan to Remove Medical Debt From Credit Reports
Health Affairs' Jeff Byers welcomes Senior Deputy Editor Rob Lott to the program to discuss a recent policy proposal that would result in prohibiting medical debt from being included in credit reporti...
26 Heinä 202413min
New Alzheimer's Drug Approval Expands Treatment Options — and Creates Coverage Questions
Health Affairs' Jeff Byers welcomes Senior Editor Leslie Erdelack to the program to discuss FDA's recent approval of an Alzheimer's treatment drug, Lilly’s Kisunla, how private insurers and Medicare m...
19 Heinä 202415min
